pocketful logo
Fermenta Biotech Ltd logo

Fermenta Biotech Ltd

NSE: BSE: 506414

₹336.60

(-0.80%)

Thu, 19 Mar 2026, 11:05 pm

mtf coin illustrationMTF 5x

Fermenta Biotech Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

  • Market Cap

    1018.46

  • Net Profit

    76.40

  • P/B

    2.20

  • Sector P/E

    31.95

  • P/E

    10.38

  • EV/EBITDA

    6.88

  • Debt/Equity (Industry)

    0.16

  • Interest Cover (Industry)

    20.07

  • ROCE (Industry)

    20.49

  • RONW (Industry)

    17.59

  • ROE

    23.45

  • ROCE

    20.20

  • Debt/Equity

    0.39

  • EPS (TTM)

    30.06

  • Dividend Yield

    0.72

  • Book Value

    132.83

  • Interest Cover

    6.59

Analysis

all

thumbs up icon

Pros

  • Dividends per share have increased over the past 10 years.
  • Dividends paid are thoroughly covered by earnings (76.6x coverage).
  • Fermenta Biotech is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Fermenta Biotech is profitable, therefore cash runway is not a concern.
  • Fermenta Biotech is profitable, therefore cash runway is not a concern.
thumbs up icon

Cons

  • Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
  • Fermenta Biotech's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
  • Fermenta Biotech's dividend is below the markets top 25% of dividend payers in India (3.08%).
  • The level of debt compared to net worth has increased over the past 5 years (20.5% vs 69.8% today).
  • Fermenta Biotech's level of debt (69.8%) compared to net worth is high (greater than 40%).

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersDEC 2025SEPT 2025JUN 2025MAR 2025DEC 2024
Promoters64.0964.0964.0964.0962.06
FII0.020.020.020.020.02
DII0.000.000.000.000.00
Public35.8935.8935.8935.8937.91
Government00000

Read More

Technical Analysis

RSI

55.94

MACD

3.70

50 DMA

327.27

200 DMA

325.11

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic419.78370.58347.97321.38298.77272.18222.98
Fibonacci370.58351.79340.18321.38302.59290.98272.18
Camarilla338.88334.37329.86321.38320.84316.33311.82

Pivots Level: Classic

R3

+98.40

419.78

R2

+49.20

370.58

R1

+26.58

347.97

321.38
321.38
Pivot Point
LTP: 341.50

S1

-22.62

298.77

S2

-49.20

272.18

S3

-98.40

222.98

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    335.67

  • 20-EMA

    332.23

  • 30-EMA

    330.41

  • 50-EMA

    327.67

  • 100-EMA

    323.34

  • 200-EMA

    318.58

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
09 Feb 2026board-meetingsQuarterly Results
11 Nov 2025board-meetingsQuarterly Results, Half Yearly Results
06 Jul 2025dividendFinal Dividend - Rs. - 2.506 Aug 2025
28 May 2025agm
28 May 2025dividend₹2.50 Dividend /Share06 Aug 2025
06 Jul 2024dividendFinal Dividend - Rs. - 1.2506 Aug 2024
27 May 2024dividend₹1.25 Dividend /Share06 Aug 2024
27 May 2024agm
22 Aug 2023dividendFinal Dividend - Rs. - 1.2522 Sept 2023
11 Aug 2023agm

Read More

Peer Comparison

Fermenta Biotech Ltd logo

Fermenta Biotech Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Lupin Ltd logo

Lupin Ltd

Read More

Fermenta Biotech Ltd About

Fermenta Biotech is engaged in the business of manufacturing and marketing of chemicals, bulk drugs, enzymes, pharmaceutical formulations and environmental solution products and renting and selling of properties. The Company caters to both domestic and international markets. The Company also has strategic investments in subsidiaries primarily dealing in manufacturing and marketing bulk drugs.

Industry

Pharmaceuticals - Indian - Bulk Drugs

Founded

1951

Headquarters

CEO

Pradeep Manjunath Chandan

Employees

Contact

Website icon

Website

http://www.fermentabiotech.com

Email icon

Email

srikant.sharma@dil.net; contact@dil.net

Phone icon

Phone

91-22-66230800/888

Location icon

Location

A-1501 DIL Complex Majiwada, Ghodbunder Road Thane One, Thane (West), Maharashtra, 400610

Read More

Fermenta Biotech Ltd Company History

YearHistory
2018
  • The Company issued Bonus Shares in the Ratio of 1:1.
2019
  • The company name was changed to Fermenta Biotech Ltd. from DIL Ltd.
2020
  • The Company issued Bonus Shares in the Ratio of 2:1.
2021
  • Fermenta received the Pride of Maharashtra Awards 2021 as the Best Company of the Year for Excellence in Exports.
  • Fermenta was awarded as the runner up in the category Excellence in R&D for the Development of new Product/ technology in India Pharma Awards 2021.
2023
  • Fermenta received the Excellence in Logistics Performance - Pharma Award at the 5th India Logistics and Warehousing Excellence Awards 2023.

Read More

Deals

Client NameOrder SideQTYAvg PriceDate
KRISHAN PREMNARAYENBuy405000255.9501 Aug 2024
EXCEL FINANCE AND INVESTMENTSSell405000255.9501 Aug 2024
IMRAN SHAUKAT CONTRACTORSell118133751.1202 Aug 2018
BP COMTRADE PVT LTDSell12050508.928 Mar 2012
GAJANAN ENTERPRISESBuy12050508.928 Mar 2012
SIXDYNE WEALTHSERVE PRIVATE LIMITEDBuy1580037430 Nov 2010
JIGAR SHAHSell1580037430 Nov 2010
SAL REAL ESTATE PRIVATE LIMITEDSell15000449.8513 Aug 2010
SHARAD SHAHBuy45668449.8513 Aug 2010
KAMAL KUMAR DUGAR AND CO ( PROP : KAMAL KUMAR DUGAR)Buy36778437.2813 Aug 2010

Read More

Fermenta Biotech Ltd News

Fermenta Biotech Q3FY26 Results: Revenue Drops 22%

Fermenta Biotech reported Q3FY26 revenue of ₹11,424.25 lakhs vs ₹14,625.23 lakhs in Q3FY25. Net profit fell to ₹1,175.92 lakhs from ₹3,499.76 lakhs YoY.

09 Feb 2026

co actions results

Fermenta Biotech Receives GST Order Worth ₹2.71 Cr

Fermenta Biotech receives GST order from Central GST Mandi Division demanding ₹1.36 cr IGST, equal penalty, and interest for alleged Rule 96(10) violation. Company expects no material impact.

31 Dec 2025

stocks

Fermenta Biotech Board Approves ₹150 Crore Fundraise

Fermenta Biotech's board has approved a proposal to raise up to ₹150 crores through various securities including equity shares, convertible instruments, and debentures via multiple modes.

10 Dec 2025

co actions results

Fermenta Biotech Approves ₹110 Cr Dahej Expansion

Fermenta Biotech approves ₹110 crore investment to expand Dahej facility for plant-based Vitamin D3, derivatives, and green chemistry enzymes production during FY26-FY27.

10 Dec 2025

stocks

Fermenta Biotech Board Approves Rs 150 Crore Fundraising Plan

Fermenta Biotech's Board of Directors approved a proposal to raise up to Rs 150 crores through various securities including equity shares, convertible debentures, or warrants via multiple modes such as public issue, rights issue, QIP, or preferential allotment. The fundraising plan requires shareholder approval and regulatory clearances, with the company planning to seek shareholder consent separately at an appropriate time.

10 Dec 2025

stock

Read More

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Stocks:

AllABCDEFGHIJKLMNOPQRSTUVWXYZ

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Others:

NSEBSECDSLNSDLSEBIMCXMSEINCDEXNSE IFSCINDIA INXAccount Closure FormDP Investor CharterBroker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800